Jeffrey Ravetch, Christopher Goodnow Win Max Cooper Prize, Get ₹84 Lakh Cash Prize
Emory University has announced the winners of its prestigious 2025 Max Cooper Prize in Immunology, with Jeffrey Ravetch and Christopher Goodnow taking home the coveted award. The prize, which comes with a cash prize of $100,000 (approximately ₹84 lakh), will be shared equally between the two researchers.
The Max Cooper Prize is a biennial award that recognizes outstanding contributions to the field of immunology. The prize is named after Max Cooper, a renowned immunologist who made significant contributions to the understanding of immune system function and disease.
Jeffrey Ravetch, a professor at The Rockefeller University, was honored for his groundbreaking work on antibody and Fc receptor interactions. His research has shed light on the complex interactions between antibodies and Fc receptors, which play a crucial role in the immune response. Ravetch’s findings have significant implications for the development of new therapies for autoimmune diseases and cancer.
Christopher Goodnow, a professor at the University of Melbourne, was recognized for his influential research on B cell tolerance and autoimmune diseases. Goodnow’s work has focused on understanding the mechanisms that govern the development of tolerance in B cells, which are a type of immune cell that produces antibodies. His research has also explored the role of B cells in autoimmune diseases, such as rheumatoid arthritis and lupus.
The Max Cooper Prize is a testament to the significant contributions that Ravetch and Goodnow have made to the field of immunology. Their work has not only advanced our understanding of the immune system but also has the potential to lead to the development of new and effective treatments for a range of diseases.
The prize was presented to Ravetch and Goodnow at a ceremony held at Emory University on July 1, 2025. The ceremony was attended by leading immunologists and researchers from around the world.
In addition to the cash prize, the winners of the Max Cooper Prize also receive a medallion and a plaque commemorating their achievement. The prize is sponsored by Emory University and is presented every two years.
The Max Cooper Prize is a significant honor in the field of immunology, and Ravetch and Goodnow are among the most esteemed researchers in the field. Their work has not only advanced our understanding of the immune system but also has the potential to lead to the development of new and effective treatments for a range of diseases.
The prize is a testament to the power of research to improve our understanding of the world and to advance human health. It is also a reminder of the importance of continued investment in basic research, which is essential for driving innovation and improving human health.
In conclusion, the awarding of the Max Cooper Prize to Jeffrey Ravetch and Christopher Goodnow is a significant milestone in the field of immunology. Their work has advanced our understanding of the immune system and has the potential to lead to the development of new and effective treatments for a range of diseases. The prize is a testament to the power of research to improve our understanding of the world and to advance human health.
Source: https://news.emory.edu/stories/2025/07/hs_max_cooper_prize_1-7-2025/story.html
